Immune Regulation, a clinical biotech company focused on resetting the immune system for treatment of inflammatory and immunological diseases, has raised £40.6M in Series B funding from investors that include Morningside Venture Investments and Metellus. Immune Regulation is led by Jonathan Rigby and was founded in 2011.
The TechWatch Media Group audience is driving progress and innovation on a global scale. With its regional media properties (London Tech, NYC Tech, LA Tech, Paris Tech, Boston Tech) TechWatch Media Group is the highway for technology and entrepreneurship. There are a number of options to reach this audience of the world’s most innovative organizations and startups at scale including having prominent brand placement in a high-visibility piece like this, which will be read by the vast majority of key influencers in the business community and beyond. All our digital content has no cancellation risk due to coronavirus or any other health hazards and engagement has been up 43%. Find out how to run a digital campaign that will return your investment here.
